Ajanta Pharma Limited Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Ajanta Pharma Limited Company Profile :

Ajanta Pharma Limited is a pharmaceutical company engaged in development, research, manufacture and marketing of quality finished dosages in domestic and international markets.

Ajanta operates with five manufacturing facilities, four in India and one in Mauritius that produce pharmaceutical products.

It is engaged in commercializing generic products and combination products in the therapeutic areas of anti-malarial, cardiovascular, dermatology, male erectile dysfunction, musculoskeletal and ophthalmology. Its manufacturing capabilities include a range of dosage forms of allopathic drugs, including tablets, capsules, ointments, injections and dry powder.


Ajanta Pharma ResultsBSE Code : 532331
NSE Symbol : AJANTPHARM
ISIN No. : INE031B01049
Industry : Pharmaceuticals
Face Value : Rs. 2.00


If you are an investor who has shares of Ajanta Pharma or you are an stock market analyst then i am sure you might for Quarterly Results of Ajanta Pharma.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Ajanta Pharma. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of Ajanta Pharma.

Ajanta Pharma Q1 Results 2016-17 :

Ajanta Pharma will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the results table below once the results are announced by the company.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Ajanta Pharma will announce its Q2 FY 2016-17 Results in the month of October 2016.

(Values in Cr.) Q2 Standalone Q2 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Ajanta Pharma will announce its Q3 FY 2016-17 Results in the month of January 2017.

(Values in Cr.) Q3 Standalone Q3 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Ajanta Pharma will announce its Q4 FY 2016-17 Results in the month of April 2017.

(Values in Cr.) Q4 Standalone Q4 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Ajanta Pharma will announce its FY 2016-17 Results in the month of April 2017.

(Values in Cr.) FY 2016-17 Standalone FY 2016-17 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS

Note : We will update the results table above as and when results are announced. Visit again.

Ajanta Pharma Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue 1551.76 1705.03
Other Income 82.35 22.50
Total Income 1634.11 1727.53
Expenditure -1035.91 -1191.87
Interest -4.20 -4.89
Depreciation -42.68 -45.06
PBT 551.32  547.40
Tax -136.84 -145.99
Net Profit 414.48 401.41
Equity 17.69 17.69
EPS 47.10 45.62

Note : If you like this information about Ajanta Pharma Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.